| VIR Snapshot | |
|---|---|
| Vir Biotechnology, Inc., a clinical-stage immunology company, develops therapeutic products to treat and prevent serious infectious diseases. The company is headquartered in San Francisco, California. | |
| VALUATION DATA | |
| Market Capitalization | $1,092,186,000 | Price to Sales | 3.00 |
| Earnings per Share | $-4.5900 |
| PE Ratio | None |
| PRICE DATA | |
| Most Recent Close | $7.6300 |
| 52 Week High | $14.05 |
| 52 Week Low | $0.761 |
| 50-Day Moving Average | $1.121 |
| 200-Day Moving Average | $0.283 |
| All data are from Alpha Vantage as of today. For more infomation on VIR see Stock Dividend, Valuation, Price and Financial Data for Investors | |
Custom Search